ClassID:

91948

C07C59/58 - CPC Classification

Classification description:

Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups; Unsaturated compounds containing ether groups, groups, groups, or groups

Sub-classes:
Recent Application in this class:
#1
20190390115
2019-12-26

Polymerizable polar compound, liquid crystal composition and liquid crystal display element

#2
20190284129
2019-09-19

LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE

#3
20180194713
2018-07-12

PROCESSES AND INTERMEDIATES FOR PREPARING alpha,omega-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS

#4
20170349560
2017-12-07

14-hydroxy-docosahexaenoic acid compounds

#5
20170320841
2017-11-09

14-hydroxy-docosahexaenoic acid compounds

#6
20170283388
2017-10-05

14-hydroxy-docosahexaenoic acid compounds

#7
20170183442
2017-06-29

POLYESTER POLYOL HAVING ALICYCLIC SKELETON

#8
20160168408
2016-06-16

Silver ink

#9
20120323011
2012-12-20

Process and intermediate compounds useful in the preparation of statins

#10
20120232143
2012-09-13

LIPID DERIVATIVES

#11
20110288317
2011-11-24

14-hydroxy-docosahexaenoic acid compounds

#12
20100323999
2010-12-23

Therapeutic Molecules and Methods-1

#13
20100216882
2010-08-26

Aspirin-triggered lipid mediators

#14
20090312555
2009-12-17

Process and intermediate compounds useful in the preparation of statins

#15
20090149538
2009-06-11

Aspirin-triggered lipid mediators

#16
20090105499
2009-04-23

Lipid derivatives

#17
20080242889
2008-10-02

Method for the production of pyruvic acid

#18
20080095711
2008-04-24

Modulators of Pulmonary Hypertension

#19
20080064660
2008-03-13

Modulation of Inflammation Related to Columnar Epithelia

#20
20070049639
2007-03-01

Aspirin-triggered lipid mediators

#21
20060154977
2006-07-13

Therapeutic molecules and methods-1

#22
20060106102
2006-05-18

Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)